Financial protection in health among the middle-aged and elderly: Evidence from the Greek economic recession.

Catastrophic health payments Cost-sharing Financial protection Greece Health coverage User charges

Journal

Health policy (Amsterdam, Netherlands)
ISSN: 1872-6054
Titre abrégé: Health Policy
Pays: Ireland
ID NLM: 8409431

Informations de publication

Date de publication:
Sep 2021
Historique:
received: 12 09 2020
revised: 18 05 2021
accepted: 21 05 2021
pubmed: 7 7 2021
medline: 1 2 2022
entrez: 6 7 2021
Statut: ppublish

Résumé

Since the late 2000s, the Greek economy has entered a long period of recession, with reforms and retrenchment in health care being among the main public policy priorities. This study investigates the extent to which financial protection in health has changed among older households during the Greek crisis. We focus on the middle-aged and elderly, the heavy users of health services, who have faced a substantial health and financial burden during the crisis. Our analysis shows that the headcount and overshoot of catastrophic health expenditure (CHE) substantially increased from 2007 to 2015, suggesting that financial protection has eroded to a great extent. Prior to the crisis, CHE was mainly due to inpatient care, followed by outpatient care and medicines. However, the contribution of spending for outpatient medicines to CHE substantially increased during the study period. The headcount of CHE rose across all socioeconomic groups we examined, with low-income households and households with chronic patients being disproportionately affected. In 2007, we do not report signs of socioeconomic inequalities in the risk of CHE. On the contrary, our results show that households of low socioeconomic status are more likely to incur CHE in 2015, revealing substantial inequalities in the risk of CHE. This finding raises significant distributional and equity concerns. Strengthening financial protection among older households is an imperative challenge for the Greek health system, and several policy responses need to be adopted towards this direction.

Identifiants

pubmed: 34226052
pii: S0168-8510(21)00137-8
doi: 10.1016/j.healthpol.2021.05.010
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1256-1266

Informations de copyright

Copyright © 2021. Published by Elsevier B.V.

Déclaration de conflit d'intérêts

Conflict of Interest statement None declared.

Auteurs

Ilias Kyriopoulos (I)

Department of Health Policy, London School of Economics and Political Science, Houghton Street, London WC2A 2AE, United Kingdom. Electronic address: i.kyriopoulos@lse.ac.uk.

Zlatko Nikoloski (Z)

Department of Health Policy, London School of Economics and Political Science, Houghton Street, London WC2A 2AE, United Kingdom. Electronic address: z.nikoloski@lse.ac.uk.

Elias Mossialos (E)

Department of Health Policy, London School of Economics and Political Science, Houghton Street, London WC2A 2AE, United Kingdom. Electronic address: e.a.mossialos@lse.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH